SECONDARY ACUTE MYELOID LEUKEMIA
Clinical trials for SECONDARY ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new SECONDARY ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for SECONDARY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for Hard-to-Treat leukemia patients
Disease control Not yet recruitingThis study tests a two-step approach for adults with a rare or treatment-related form of acute myeloid leukemia (AML). First, patients receive a combination of two drugs (venetoclax and azacitidine) to reduce cancer cells. Then, they receive a stem cell transplant from a donor to…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
New attack on hidden leukemia: can combo drugs wipe out remaining cancer before transplant?
Disease control Not yet recruitingThis study tests whether adding newer drugs to standard chemotherapy can better eliminate leftover leukemia cells in adults (ages 18-59) before a stem cell transplant. About 184 participants will receive one of four treatment combinations. The goal is to achieve a deeper remissio…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC